Clinical Trial: Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene

Brief Summary: To assess the effect of oral administration of the alga Dunaliella bardawil containing approximately 50% all-trans beta-carotene and 50% 9-cis beta-carotene isomers on visual functions patients with Congenital Stationary Night Blindness {Fundus albipunctatus).

Detailed Summary:
Sponsor: Sheba Medical Center

Current Primary Outcome: Electroretinogram responses [ Time Frame: Three months ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Visual acuity [ Time Frame: Three Months ]

Original Secondary Outcome: Same as current

Information By: Sheba Medical Center

Dates:
Date Received: December 5, 2007
Date Started: July 2007
Date Completion:
Last Updated: June 26, 2012
Last Verified: June 2012